These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31276975)

  • 1. Mechanism of action of celastrol against rheumatoid arthritis: A network pharmacology analysis.
    Song X; Zhang Y; Dai E; Du H; Wang L
    Int Immunopharmacol; 2019 Sep; 74():105725. PubMed ID: 31276975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of celastrol in the treatment of systemic lupus erythematosus based on network pharmacology and molecular docking technology.
    Xinqiang S; Yu Z; Ningning Y; Erqin D; Lei W; Hongtao D
    Life Sci; 2020 Jan; 240():117063. PubMed ID: 31734262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of triptolide targets in rheumatoid arthritis using network pharmacology and molecular docking.
    Song X; Zhang Y; Dai E; Wang L; Du H
    Int Immunopharmacol; 2020 Mar; 80():106179. PubMed ID: 31972422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics.
    Zeng L; Yu G; Yang K; He Q; Hao W; Xiang W; Long Z; Chen H; Tang X; Sun L
    Sci Rep; 2024 Jan; 14(1):1604. PubMed ID: 38238321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes.
    Wu M; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():1030278. PubMed ID: 36339449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative transcriptomics and network pharmacology analysis to identify the potential mechanism of celastrol against osteoarthritis.
    Dai S; Wang H; Wang M; Zhang Y; Zhang Z; Lin Z
    Clin Rheumatol; 2021 Oct; 40(10):4259-4268. PubMed ID: 33870466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential mechanisms of action of celastrol against rheumatoid arthritis: Transcriptomic and proteomic analysis.
    Xinqiang S; Erqin D; Yu Z; Hongtao D; Lei W; Ningning Y
    PLoS One; 2020; 15(7):e0233814. PubMed ID: 32726313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network pharmacology approach to explore the potential targets underlying the effect of sinomenine on rheumatoid arthritis.
    Guo X; Ji J; Feng Z; Hou X; Luo Y; Mei Z
    Int Immunopharmacol; 2020 Mar; 80():106201. PubMed ID: 31972421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of CLEC2B as a diagnostic biomarker and screening of celastrol as a candidate drug for psoriatic arthritis through bioinformatics analysis.
    Niu M; Yuan J; Yan M; Yang G; Yan Z; Yang X
    J Orthop Surg Res; 2023 May; 18(1):390. PubMed ID: 37246213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modulators of celastrol as the keystones for its diverse pharmacological activities.
    Ng SW; Chan Y; Chellappan DK; Madheswaran T; Zeeshan F; Chan YL; Collet T; Gupta G; Oliver BG; Wark P; Hansbro N; Hsu A; Hansbro PM; Dua K; Panneerselvam J
    Biomed Pharmacother; 2019 Jan; 109():1785-1792. PubMed ID: 30551432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celastrol as a candidate drug for silicosis: From bioinformatics and network pharmacology to experimental validation.
    Liang C; Bai Y; Miao R; Yang X; Gao L; Liu Y; Zhou J; Guo J; Hu D; Wu J
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111068. PubMed ID: 37948856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol induced DNA damage, cell cycle arrest, and apoptosis in human rheumatoid fibroblast-like synovial cells.
    Xu Z; Wu G; Wei X; Chen X; Wang Y; Chen L
    Am J Chin Med; 2013; 41(3):615-28. PubMed ID: 23711145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of CD68 Synovial Macrophages in Celastrol Treated Arthritic Rats.
    Cascão R; Vidal B; Lopes IP; Paisana E; Rino J; Moita LF; Fonseca JE
    PLoS One; 2015; 10(12):e0142448. PubMed ID: 26658436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revealing the Synergistic Mechanism of Multiple Components in Compound Fengshiding Capsule for Rheumatoid Arthritis Therapeutics by Network Pharmacology.
    Duan H; Zhai KF; Khan GJ; Zhou J; Cao TY; Wu YQ; Zhou YR; Cao WG; Gao GZ; Shan LL
    Curr Mol Med; 2019; 19(4):303-314. PubMed ID: 30950348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Potential of Capsaicin Against Cancer Metastasis Based on TGF-β Signaling Modulation Through Module-based Network Pharmacology Approachx.
    Kandagalla S; Shekarappa SB; Pavan G; Hani U; Hanumanthappa M
    Curr Drug Discov Technol; 2020; 17(5):647-660. PubMed ID: 31113351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of autoimmune inflammation by celastrol, a natural triterpenoid.
    Venkatesha SH; Dudics S; Astry B; Moudgil KD
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27405485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celastrol and Its Role in Controlling Chronic Diseases.
    Venkatesha SH; Moudgil KD
    Adv Exp Med Biol; 2016; 928():267-289. PubMed ID: 27671821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro "benefit-risk" evaluation and network regulation mechanism of Colquhounia Root Tablets and its key material basis].
    Wang KX; Mao X; Zhang YG; Wu AG; Su XH; Wang JR; Cai BL; Lin N; Huang F
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(23):6438-6449. PubMed ID: 36604890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the Effect of Celastrol Against Ovarian Cancer With Network Pharmacology and
    Wang X; Liu Q; Wu S; Xu N; Li H; Feng A
    Front Pharmacol; 2022; 13():739478. PubMed ID: 35370699
    [No Abstract]   [Full Text] [Related]  

  • 20. Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis.
    Han X; Sun S; Zhao M; Cheng X; Chen G; Lin S; Guan Y; Yu X
    PLoS One; 2014; 9(11):e112470. PubMed ID: 25383959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.